Effects of Autologous Stem Cell Transplantation in HIV: Searching for the Origins of Viral Replication in Settings of Profound CD4 + T Cell Depletion

Abstract

Get full access to this article

View all access options for this article.

References

Bortolin

, Zanussi

, Talamini

et al.

Predictive value of HIV type 1 DNA levels on overall survival in HIV-related lymphoma Patients treated with high-dose chemotherapy (HDC) plus autologous stem cell transplantation (ASCT)

AIDS Res Hum Retroviruses, 2010; 26:245–251.

Perelson

, Neumann

, Markowitz

, Leonard

, Ho

. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation. Science, 1996; 271:1582–1586.

Gabarre

, Marcelin

, Azar

et al. High-dose therapy plus autologous haematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: Results and impact on HIV disease. Haematologica, 2004; 89:1100–1108.

Bailey

, Sedaghat

, Kieffer

et al. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. J Virol, 2006; 80:6441–6457.

Brennan

, Woods

, Sedaghat

, Siliciano

, Wilke

. Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy. J Virol, 2009; 83:8470–8481.

Mackall

, Fry

, Gress

, Peggs

, Storek

, Toubert

. Background to hematopoietic cell transplantation, including post transplant immune recovery. Bone Marrow Transplant, 2009; 44:457–462.

Simonelli

, Zanussi

, Pratesi

et al. Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma. Clin Infect Dis, 2010; 50:1672–1679.